Hengtong(SH:600226) Zheng Quan Zhi Xing·2025-08-25 16:30Core Viewpoint - Zhejiang Hengtong Holdings Co., Ltd. reported significant growth in revenue and total assets for the first half of 2025, indicating a strong operational performance despite a decline in net profit attributable to shareholders [1][2]. Financial Performance - Total assets increased to CNY 4,813.56 million, up 7.07% from the previous year [1]. - Operating revenue reached CNY 818.21 million, representing a 45.80% increase compared to the same period last year [1]. - Total profit amounted to CNY 140.72 million, a 16.68% rise year-on-year [1]. - Net profit attributable to shareholders decreased by 29.36% to CNY 78.33 million, excluding non-recurring gains and losses [1]. Cash Flow and Shareholder Information - The net cash flow from operating activities was negative at CNY -62.05 million, compared to CNY -48.74 million in the previous year [1]. - The total number of shareholders as of the reporting period was 34,237 [1]. Major Shareholders - Hengtong Group Co., Ltd. holds 16.95% of the shares, amounting to 504,153,332 shares, and is the controlling shareholder [2]. - Other significant shareholders include Suzhou Hengtong Yongxu Venture Capital with 10.83% and Zhangjiagang Puxin Enterprise Management Consulting with 5.24% [2]. Important Developments - The company is set to enhance its production capacity with the completion of a small amino acid production base project, which will add 11,880 tons/year of production capacity, including L-Tryptophan and L-Arginine [5].